NPM1 and myelodysplastic syndrome: there was no emerged mutations after MDS/AML diagnosis, but at least one of the baseline gene mutations involved one of following pathway: activated signaling, myeloid transcriptional factors, tumor suppressors or NPM1, and the AML occurred in less than one year from MDS diagnosis (transformation style1 in Fig. 4).